A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma

A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma

This review aims to summarize the putative role of histone deacetylases (HDACs) in rhabdomyosarcoma (RMS) and the effects of HDAC inhibitors (HDACi) on RMS by elucidating and highlighting known oncogenic pathways, mechanisms of resistance, and the synergistic potential of histone deacetylase inhibit...

Full description

Bibliographic Details
Main Authors:	Omar Selim, Clara Song, Amy Kumar, Rebecca Phelan, Arun Singh, Noah Federman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Oncology
Subjects:	rhabdomyosarcoma histone deacetylase inhibitors pediatric cancer clinical trials mutations
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1244035/full

Similar Items

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
by: Kim Freese, et al.
Published: (2019-10-01)

Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
by: Svetlana Demyanenko, et al.
Published: (2021-10-01)

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
by: Amandine Badie, et al.
Published: (2022-11-01)

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
by: Fengyi Guo, et al.
Published: (2022-11-01)

Advanced Progress of Histone Deacetylases in Rheumatic Diseases
by: Liu XM, et al.
Published: (2024-02-01)

The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
by: Dineo eKhabele
Published: (2014-05-01)

Design, synthesis, and biological evaluation of novel histone deacetylase 6 selective inhibitors
by: Tianyi Zhang, et al.
Published: (2022-05-01)

Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
by: Surabhi Shukla, et al.
Published: (2020-04-01)

The application of histone deacetylases inhibitors in glioblastoma
by: Rui Chen, et al.
Published: (2020-07-01)

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
by: Long Xu, et al.
Published: (2023-10-01)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021-01-01)

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies
by: Martina Sandonà, et al.
Published: (2023-02-01)

Subcellular localization of class I histone deacetylases in the developing Xenopus tectum
by: Xia eGuo, et al.
Published: (2016-01-01)

Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus
by: Xiaojie Wang, et al.
Published: (2012-08-01)

The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
by: Duong Tien Anh, et al.
Published: (2023-02-01)

Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents
by: Subhasish Tapadar, et al.
Published: (2020-10-01)

Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
by: Tandon N, et al.
Published: (2016-05-01)

Targeted inhibition of histone deacetylase 6 in inflammatory diseases
by: Jie Ran, et al.
Published: (2019-03-01)

Screening of selective histone deacetylase inhibitors by proteochemometric modeling
by: Wu Dingfeng, et al.
Published: (2012-08-01)

Role of Histone Deacetylases in T-Cell Development and Function
by: Monika Pieniawska, et al.
Published: (2022-07-01)

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
by: Marinella Zilli, et al.
Published: (2013-07-01)

The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
by: Iason Psilopatis, et al.
Published: (2023-04-01)

Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
by: Wenli Fan, et al.
Published: (2021-01-01)

Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
by: Yiming Chen, et al.
Published: (2021-01-01)

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
by: Yu Han, et al.
Published: (2022-07-01)

Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
by: Ana Vuletić, et al.
Published: (2023-12-01)

Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases
by: Jianglei Li, et al.
Published: (2022-05-01)

Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
by: Fabian B. Kraft, et al.
Published: (2023-02-01)

Synthesis and Crystal Structure Analysis of Histone Deacetylase Inhibitor Chidamide
by: Bo Han, et al.
Published: (2023-06-01)

Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
by: Guang Lu, et al.
Published: (2023-08-01)

In silico profiling of histone deacetylase inhibitory activity of compounds isolated from Cajanus cajan
by: Kayode Adewole, et al.
Published: (2022-01-01)

Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke
by: Ying Tang, et al.
Published: (2017-10-01)

Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
by: Alexandre Perla, et al.
Published: (2020-07-01)

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
by: Donya Naz Divsalar, et al.
Published: (2020-06-01)

Histone Deacetylase Inhibition: An Important Mechanism in the Treatment of Lymphoma
by: Shan-qi Guo, et al.
Published: (2012-06-01)